Piper Sandler Reiterates Overweight on Sight Sciences, Raises Price Target to $12
Piper Sandler analyst Adam Maeder reiterates Sight Sciences (NASDAQ:SGHT) with a Overweight and raises the price target from $9 to $12.
Share
Why It Matters
A stock expert believes Sight Sciences is a good company to own. They think the stock could be worth more money than before.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.